Cefuroxime Renal Dose Adjustment for Cellulitis
For adults with cellulitis, cefuroxime should be dosed at 750 mg every 8 hours for normal renal function (CrCl >20 mL/min), 750 mg every 12 hours for CrCl 10-20 mL/min, and 750 mg every 24 hours for CrCl <10 mL/min, with an additional dose after hemodialysis if applicable. 11
Standard Dosing for Cellulitis
For uncomplicated skin and skin-structure infections including cellulitis, the FDA-approved dosing is 750 mg every 8 hours, typically for 5-10 days 11. This represents the lower end of the cefuroxime dosing range (750 mg to 1.5 grams every 8 hours), as cellulitis is generally considered an uncomplicated infection unless there are complicating factors.
Renal Function-Based Dosing Algorithm
The dosing adjustments are straightforward and based on creatinine clearance 11:
Normal Renal Function (CrCl >20 mL/min)
- Dose: 750 mg every 8 hours
- No adjustment needed from standard dosing
Moderate Renal Impairment (CrCl 10-20 mL/min)
- Dose: 750 mg every 12 hours
- Extends the dosing interval by 50%
Severe Renal Impairment (CrCl <10 mL/min)
- Dose: 750 mg every 24 hours
- Extends the dosing interval to once daily
- Critical: Give an additional 750 mg dose after each hemodialysis session, as cefuroxime is dialyzable 11
Calculating Creatinine Clearance
When only serum creatinine is available, use the Cockcroft-Gault equation 1:
Males: CrCl (mL/min) = [Weight (kg) × (140 - age)] / [72 × serum creatinine (mg/dL)]
Females: 0.85 × male value
The serum creatinine must represent steady-state renal function for accurate calculation.
Clinical Context and Rationale
Cefuroxime demonstrates appropriate activity against the typical pathogens causing cellulitis—primarily β-hemolytic streptococci and methicillin-sensitive Staphylococcus aureus 2. The drug is approximately 89% renally excreted, making dose adjustment essential in renal impairment to prevent accumulation 1.
Pharmacokinetic studies confirm that the elimination half-life increases dramatically with declining renal function—from approximately 1.7 hours with normal function to 17.6 hours when CrCl is <20 mL/min 3. In severe renal impairment (CrCl ≤23 mL/min), half-life can extend to 22.3 hours 4. These prolonged half-lives necessitate the interval extensions outlined above to maintain therapeutic concentrations while avoiding toxicity.
Important Caveats
Duration of therapy: Continue treatment for a minimum of 48-72 hours after the patient becomes asymptomatic or shows evidence of bacterial eradication 11. For streptococcal infections, a minimum 10-day course is recommended to prevent rheumatic fever or glomerulonephritis.
Monitoring: The serum creatinine should represent steady-state renal function when calculating clearance. Reassess renal function if clinical status changes during treatment.
Hemodialysis patients: The additional post-dialysis dose is non-negotiable, as a significant amount of drug is removed during dialysis 11.
Avoid underdosing: Do not use doses smaller than those specified, as this increases the risk of treatment failure and potential resistance development 11.